Cited by 149Acute Lymphoblastic Leukemia researchAmino Acid Enzymes and MetabolismRetinoids in leukemia and cellular processes

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL

Open access

Stams, W. A. G.·2003·Blood

DOI 10.1182/blood-2002-08-2446

Open this paper in CoChat — free account Open PDF

Abstract

The (12;21) translocation resulting in TEL/AML1 gene fusion is present in about 25% of childhood precursor B-lineage acute lymphoblastic leukemia (ALL) and is associated with a good prognosis and a high cellular sensitivity to L-asparaginase (L-Asp). ALL cells are thought to be sensitive to L-Asp due to lower asparagine synthetase (AS) levels. Resistance to L-Asp may be caused by an elevated cellular level of AS or by the ability of resistant cells to rapidly induce the expression of the AS gene on L-Asp exposure. AS may be a target regulated by t(12;21). We studied the relationship between t(12;21) and the mRNA level of AS to investigate a possible mechanism underlying L-Asp sensitivity. Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis surprisingly revealed that 30 patients positive for t(12;21) expressed 5-fold more AS mRNA compared with 17 patients negative for t(12;21) (P =.008) and 11 samples from healthy controls (P =.016). The mRNA levels of AS between t(12;21)(-) ALL and healthy controls did not differ. No difference was found between ALL patients positive or negative for t(12;21) in the capacity to up-regulate AS after in vitro L-Asp exposure, excluding a defective capacity for t(12;21) cells in up-regulating AS on L-Asp exposure. Moreover, no correlation was observed between AS mRNA expression and sensitivity to L-Asp. We conclude that the sensitivity of t(12;21)(+) childhood ALL to L-Asp is not associated with the expression level of the AS gene. Furthermore, we contradict the general thought that leukemic cells specifically lack AS compared with normal bone marrow and blood cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood-2002-08-2446

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Identification of AML-1 and the (8;21) Translocation Protein (AML-1/ETO) as Sequence-Specific DNA-Binding Proteins: theruntHomology Domain is Required for DNA Binding and Protein-Protein Interactions
Meyers, S., Downing, J. R., & Hiebert, S. W. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6336 · Cited by 462
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
McLean, T., Ringold, S., Neuberg, D. S., Stegmaier, K., Tantravahi, R. V., Ritz, J., Koeffler, H., Takeuchi, S., Janssen, J. W. G., Seriu, T., et al. (1996) · Blood · doi:10.1182/blood.v88.11.4252.4252 · Cited by 319
Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials
Borkhardt, A., Cazzaniga, G., Viehmann, S. F., Valsecchi, M. G., Ludwig, W. D., Burci, L., Mangioni, S., Schrappe, M., Riehm, H., Lampert, F. H., et al. (1997) · Blood · doi:10.1182/blood.v90.2.571 · Cited by 314
A Novel Method to Compensate for Different Amplification Efficiencies between Patient DNA Samples in Quantitative Real-Time PCR
Meijerink, J. P. P., Mandigers, C. M. P. W., van de Locht, L. T., Tönnissen, E., Goodsaid, F. M., & Raemaekers, J. M. M. (2001) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60652-6 · Cited by 298
In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia
Kaspers, G. J. L., Veerman, A. J. P., Pieters, R., van Zantwijk, C. H., Smets, L. A., van Wering, E. R., & den Berg, A. V. D. D.-V. (1997) · Blood · doi:10.1182/blood.v90.7.2723 · Cited by 272
The t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription
Hiebert, S. W., Sun, W., Nathan Davis, J., Golub, T., Shurtleff, S., Buijs, A., Downing, J. R., Grosveld, G., Roussel, M. F., Gary Gilliland, D., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1349 · Cited by 272
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions
Pieters, R., Loonen, A. H., Huismans, D. R., Broekema, G., Dirven, M., Heyenbrok, M., Hählen, K., & Veerman, A. J. P. (1990) · Blood · doi:10.1182/blood.v76.11.2327.2327 · Cited by 232
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia
Pieters, R., Huismans, D. R., Loonen, A. H., Veerman, A. J. P., Hählen, K., den Berg, A. V. D. D.-V., & Wering, E. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)91029-t · Cited by 216
TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia
Seeger, K., Adams, H.-P., Buchwald, D., Beyermann, B., Kremens, B., Niemeyer, C. M., Ritter, J., Schwabe, D., Harms, D., Schrappe, M., et al. (1998) · Blood · doi:10.1182/blood.v91.5.1716 · Cited by 174
Incidence of TEL/AML1 Fusion Gene Analyzed Consecutively in Children With Acute Lymphoblastic Leukemia in Relapse
Harbott, J., Viehmann, S. F., Borkhardt, A., Henze, G., & Lampert, F. (1997) · Blood · doi:10.1182/blood.v90.12.4933 · Cited by 161

Show all 35 references

Sorted by citations

Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,369
Acute Lymphoblastic Leukemia
Pui, C., Relling, M. V., & Downing, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra023001 · Cited by 1,182
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Cancer Cell Metabolism: One Hallmark, Many Faces
Cantor, J. R., & Sabatini, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0345 · Cited by 989
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
Narta, U. K., Kanwar, S. S., & Azmi, W. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.009 · Cited by 383
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
Iwamoto, S., Mihara, K., Downing, J. R., Pui, C., & Campana, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30235 · Cited by 336
Asparagine Synthetase Chemotherapy
Richards, N. G. J., & Kilberg, M. S. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142520 · Cited by 244
Asparagine synthetase: regulation by cell stress and involvement in tumor biology
Balasubramanian, M. N., Butterworth, E. A., & Kilberg, M. S. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2013 · Cited by 243
Glutamine Metabolism in Cancer
Li, T., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_2 · Cited by 242
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia
Tong, W. H., Pieters, R., Kaspers, G. J. L., Loo, D. M. W. M. T., Bierings, M., van den Bos, C., Kollen, W. J. W., Hop, W. C. J., Lanvers‐Kaminsky, C., Relling, M. V., et al. (2014) · Blood · doi:10.1182/blood-2013-10-534347 · Cited by 225
Current applications and different approaches for microbial l-asparaginase production
Cachumba, J. J. M., Antunes, F. A. F., Peres, G. F. D., Brumano, L. P., Santos, J. C. F. S., & da Silva, S. S. (2016) · Brazilian Journal of Microbiology · doi:10.1016/j.bjm.2016.10.004 · Cited by 210
Adipocytes Cause Leukemia Cell Resistance to L -Asparaginase via Release of Glutamine
Ehsanipour, E. A., Sheng, X., Behan, J. W., Wang, X., Butturini, A. M., Avramis, V. I., & Mittelman, S. D. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4402 · Cited by 189
Asparagine Synthetase in Cancer: Beyond Acute Lymphoblastic Leukemia
Chiu, M., Taurino, G., Bianchi, M. G., Kilberg, M. S., & Bussolati, O. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01480 · Cited by 168
Selective apoptosis of natural killer‐cell tumours by l ‐asparaginase
Ando, M., Sugimoto, K., Kitoh, T., Sasaki, M., Mukai, K., Ando, J., Egashira, M., Schuster, S. M., & Oshimi, K. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05694.x · Cited by 161
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia
Lugthart, S., Cheok, M. H.-C., den Boer, M. L., Yang, W., de Haar-Holleman, A., Cheng, C., Pui, C., Relling, M. V., Janka-Schaub, G. E., Pieters, R., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.002 · Cited by 160
The effects of dietary fatty acids on liver fatty acid composition and Δ6-desaturase expression differ with ambient salinities in Siganus canaliculatus
Li, Y., Hu, C.-B., Zheng, Y., Xia, X.-A., Xu, W., Wang, S., Chen, W., Ze-wei, S., & Huang, J.-H. (2008) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2008.06.013 · Cited by 153
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia
de Haar-Holleman, A. (2005) · Blood · doi:10.1182/blood-2005-07-2930 · Cited by 142
A Novel l -Asparaginase with low l -Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo
Nguyen, H. A. T., Su, Y., Zhang, J. Y., Antanasijevic, A., Caffrey, M. S., Schalk, A. M., Liu, L., Rondelli, D., Oh, A. L., Mahmud, D. L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2106 · Cited by 130
Glutamine Metabolism in Cancer
Li, T., Copeland, C., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_2 · Cited by 134
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01
Loh, M. L., Goldwasser, M. A., Silverman, L. B., Poon, W.-M., Vattikuti, S., Cardoso, A. A., Neuberg, D. S., Shannon, K., Sallan, S. E., & Gilliland, D. G. (2006) · Blood · doi:10.1182/blood-2005-08-3451 · Cited by 120
A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug l-asparaginase
Patel, N. R., Krishnan, S., Offman, M. N., Król, M., Moss, C., Leighton, C., van Delft, F. W., Holland, M., Liu, J., Alexander, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37977 · Cited by 117
Asparaginases: biochemical pharmacology and modes of drug resistance.
Avramis, V. I. (2012) · PubMed · Cited by 115
Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase
Reinert, R. B., Oberle, L. M., Wek, S. A., Bunpo, P., Wang, X. P., Mileva, I., Goodwin, L. O., Aldrich, C. J., Durden, D. L., McNurlan, M. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604511200 · Cited by 107
Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias
Hinze, L., Pfirrmann, M., Karim, S., Degar, J., McGuckin, C., Vinjamur, D. S., Sacher, J. R., Stevenson, K. E., Neuberg, D. S., Orellana, E. A., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.004 · Cited by 103
Biology and Treatment of Acute Lymphoblastic Leukemia
Pieters, R., & Carroll, W. L. (2008) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2007.11.002 · Cited by 105
Asparagine synthetase as a causal, predictive biomarker for l -asparaginase activity in ovarian cancer cells
Lorenzi, P. L., Reinhold, W. C., Rudelius, M., Gunsior, M., Shankavaram, U. T., Bussey, K. J., Scherf, U., Eichler, G. S., Martin, S. E., Chin, K., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0447 · Cited by 105
A Genome-Wide View of the In vitro Response to l-Asparaginase in Acute Lymphoblastic Leukemia
Fine, B. M., Kaspers, G. J. L., Ho, M., Loonen, A. H., & Boxer, L. M. (2005) · Cancer Research · doi:10.1158/0008-5472.291.65.1 · Cited by 103
Asparagine: A Metabolite to Be Targeted in Cancers
Jiang, J., Batra, S., & Zhang, J. (2021) · Metabolites · doi:10.3390/metabo11060402 · Cited by 99
Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines
Su, N. Y., Pan, Y., Zhou, M., Harvey, R. C., Hunger, S. P., & Kilberg, M. S. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21213 · Cited by 96
PEG-asparaginase
Fu, C. H., & Sakamoto, K. M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.12.1977 · Cited by 94
Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma
Zhang, B., Dong, L., Tan, Y.-X., Zhang, J., Pan, Y.-F., Yang, C. Z., Li, M.-H., Ding, Z.-W., Liu, L., Jiang, T.-Y., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.293 · Cited by 92
Asparagine synthetase is a predictive biomarker of l -asparaginase activity in ovarian cancer cell lines
Lorenzi, P. L., Llamas, J., Gunsior, M., Ozbun, L. L., Reinhold, W. C., Varma, S., Ji, H., Kim, H., Hutchinson, A. A., Kohn, E. C., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0589 · Cited by 91
Targeting extracellular nutrient dependencies of cancer cells
García‐Bermúdez, J., Williams, R. T., Guarecuco, R., & Birsoy, K. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.011 · Cited by 93
Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia
Stams, W. A. G. (2005) · Blood · doi:10.1182/blood-2004-10-3892 · Cited by 86
Self-citation
Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).
Panosyan, E. H., Grigoryan, R. S., Avramis, I. A., Seibel, N. L., Gaynon, P. S., Siegel, S. E., Fingert, H. J., & Avramis, V. I. (2004) · PubMed · Cited by 78
Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells
Takahashi, H., Inoue, J., Sakaguchi, K., Takagi, M., Mizutani, S., & Inazawa, J. (2017) · Oncogene · doi:10.1038/onc.2017.59 · Cited by 77
SLC1A3 contributes to L‐asparaginase resistance in solid tumors
Sun, J., Nagel, R., Zaal, E. A., Ugalde, A. P., Han, R., Proost, N., Song, J., Pataskar, A., Burylo, A. M., Fu, H., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2019102147 · Cited by 69
Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia
Appel, I. M., den Boer, M. L., Meijerink, J. P. P., Veerman, A. J. P., Reniers, N. C. M., & Pieters, R. (2006) · Blood · doi:10.1182/blood-2005-06-2597 · Cited by 70
Biology and Treatment of Acute Lymphoblastic Leukemia
Pieters, R., & Carroll, W. L. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.11.014 · Cited by 64
Asparaginase pharmacology: challenges still to be faced
Lanvers‐Kaminsky, C. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3236-y · Cited by 61
Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase
Heřmanová, I., Zaliova, M. K., Trka, J., & Starková, J. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.04.005 · Cited by 58
Pegasparaginase: where do we stand?
Zeidan, A. M., Wang, E. S., & Wetzler, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712590802586058 · Cited by 58
Inhibition of Glutamine Synthetase Triggers Apoptosis in Asparaginase-Resistant Cells
Rotoli, B. M., Uggeri, J., Dall’Asta, V., Visigalli, R., Barilli, A., Gatti, R., Orlandini, G., Gazzola, G. C., & Bussolati, O. (2005) · Cellular Physiology and Biochemistry · doi:10.1159/000087238 · Cited by 56
The why and how of amino acid analytics in cancer diagnostics and therapy
Manig, F., Kuhne, K., von Neubeck, C., Schwarzenbolz, U., Yu, Z., Kessler, B. M., Pietzsch, J., & Kunz‐Schughart, L. A. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.12.001 · Cited by 55
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity
Chen, S.-H., Yang, W., Fan, Y., Stocco, G., Crews, K. R., Yang, J. J. J., Paugh, S. W., Pui, C.-H., Evans, W. E., & Relling, M. V. (2010) · Leukemia · doi:10.1038/leu.2010.256 · Cited by 55
Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia
Burke, M. J., & Rheingold, S. R. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1213826 · Cited by 53
Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells
Krejci, O., Starková, J., Otová, B., Madžo, J., Kalinová, M., Hrušák, O., & Trka, J. (2004) · Leukemia · doi:10.1038/sj.leu.2403259 · Cited by 52
Structure and function of the thermostable L -asparaginase fromThermococcus kodakarensis
Guo, J., Coker, A. R., Wood, S., Cooper, J. B., Chohan, S. M., Rashid, N., & Akhtar, M. (2017) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798317014711 · Cited by 52
Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
Chen, S. (2014) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2014.10.006 · Cited by 51
The inhibition of glutamine synthetase sensitizes human sarcoma cells to l-asparaginase
Tardito, S., Uggeri, J., Bozzetti, C., Bianchi, M. G., Rotoli, B. M., Franchi‐Gazzola, R., Gazzola, G. C., Gatti, R., & Bussolati, O. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0421-z · Cited by 51
Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia
Jędraszek, K., Malczewska, M., Parysek-Wójcik, K., & Lejman, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063067 · Cited by 57
Cerebrovascular protection of β-asarone in Alzheimer's disease rats: A behavioral, cerebral blood flow, biochemical and genic study
Li, Z., Zhao, G., Qian, S., Yang, Z., Chen, X., Chen, J., Cai, C., Liang, X., & Guo, J. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.09.013 · Cited by 49
Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies
Ardalan, N., Mirzaie, S., Sepahi, A. A., & Khavari‐Nejad, R. A. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.01.004 · Cited by 49
Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome
Stams, W. A. G., Beverloo, H. B., den Boer, M. L., de Menezes, R. X., Stigter, R., van Drunen, E., Woerden, N. L. R.-V., Loonen, A. H., van Wering, E. R., Janka-Schaub, G. E., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404083 · Cited by 49
Self-citation
HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway
Lee, J. K., Kang, S., Wang, X., Rosales, J. L., Gao, X., Byun, H., Jin, Y., Fu, S., Wang, J., & Lee, K. (2019) · Blood · doi:10.1182/blood-2018-12-890236 · Cited by 45
A clinically attainable dose of L‐asparaginase targets glutamine addiction in lymphoid cell lines
Sugimoto, K., Suzuki, H. I., Fujimura, T., Ono, A., Kaga, N., Isobe, Y., Sasaki, M., Taka, H., Miyazono, K., & Komatsu, N. (2015) · Cancer Science · doi:10.1111/cas.12807 · Cited by 42
Epigenetic Silencing Affects l -Asparaginase Sensitivity and Predicts Outcome in T-ALL
Touzart, A., Lengliné, É., Latiri, M., Belhocine, M., Smith, C. L., Thomas, X., Spicuglia, S., Puthier, D., Pflumio, F., Leguay, T., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1844 · Cited by 42
Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli
Einsfeldt, K., Baptista, I. C., Pereira, J. C. C. V., Costa‐Amaral, I. C., da Costa, E. S., Ribeiro, M. C. M., Land, M. G. P., Alves, T. L. M., Larentis, A. L., & Almeida, R. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156692 · Cited by 39
Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia
Zhou, R., Liang, T., Li, T., Huang, J., & Chen, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1070069 · Cited by 37
Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia
Zwaan, C. M., & Kaspers, G. J. L. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05167.x · Cited by 38
Asparaginase production by endophytic fungi from Thai medicinal plants: cytoxicity properties.
Theantana, T., Hyde, K. D., & Lumyong, S. (2009) · International journal of integrative biology · Cited by 36
Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression
Grima-Reyes, M., Vandenberghe, A., Nemazanyy, I., Meola, P., Paul, R., Reverso-Meinietti, J., Martinez-Turtos, A., Nottet, N., Chan, W., Lorenzi, P. L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn6491 · Cited by 31
Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines
Chien, W. W., Beux, C. L., Rachinel, N., Julien, M., Lacroix, C., Allas, S., Sahakian, P., Cornut-Thibaut, A., Lionnard, L., Kucharczak, J., et al. (2015) · Scientific Reports · doi:10.1038/srep08068 · Cited by 33
The use of KnockOut serum replacement (KSR) in three dimensional rat testicular cells co-culture model: An improved male reproductive toxicity testing system
Zhang, X., Wang, L., Zhang, X., Ren, L., Shi, W., Tian, Y., Jiangbo, Z., & Zhang, T. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.001 · Cited by 33
Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells
Akagi, T., Yin, D., Kawamata, N., Bartram, C. R., Hofmann, W.-K., Wolf, I., Miller, C. W., & Koeffler, H. P. (2006) · Leukemia · doi:10.1038/sj.leu.2404216 · Cited by 32
In vitro efficacy of l ‐asparaginase in childhood acute myeloid leukaemia
Okada, S., Hongo, T., Yamada, S., Watanabe, C., Fujii, Y., Ohzeki, T., Horikoshi, Y., Ito, T., Yazaki, M., Komada, Y., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04703.x · Cited by 32
Downregulation of phosphatase of regenerating liver-3 is involved in the inhibition of proliferation and apoptosis induced by emodin in the SGC-7901 human gastric carcinoma cell line
Sun, Z., & Bu, P. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.516 · Cited by 31
Genome-wide loss-of-function genetic screening identifies opioid receptor μ1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia
Kang, S., Rosales, J. L., Meier‐Stephenson, V., Kim, S., Lee, K. Y., & Narendran, A. (2017) · Oncogene · doi:10.1038/onc.2017.211 · Cited by 31
L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase
Blachier, J., Cleret, A., Guérin, N., Gil, C., Fanjat, J.-M., Tavernier, F., Vidault, L., Gallix, F., Rama, N., Rossignol, R., et al. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113568 · Cited by 31
Update on the Use of L-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia
Andrade, A. F., Borges, K. S., & Silveira, V. S. (2014) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s10242 · Cited by 30
Engineering of Helicobacter pylori L-Asparaginase: Characterization of Two Functionally Distinct Groups of Mutants
Maggi, M., Chiarelli, L. R., Valentini, G., & Scotti, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117025 · Cited by 30
Epigenetic changes in the repression and induction of asparagine synthetase in human leukemic cell lines
Ding, Y., Li, Z., & Broome, J. D. (2005) · Leukemia · doi:10.1038/sj.leu.2403639 · Cited by 30
How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic review
Brigitha, L. J., Pieters, R., & van der Sluis, I. M. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.08.025 · Cited by 28
Expression Levels of TEL, AML1, and the Fusion Products TEL-AML1 and AML1-TEL versus Drug Sensitivity and Clinical Outcome in t(12;21)-Positive Pediatric Acute Lymphoblastic Leukemia
Stams, W. A. G., den Boer, M. L., Beverloo, H. B., Meijerink, J. P. P., van Wering, E. R., Janka-Schaub, G. E., & Pieters, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1829 · Cited by 27
Self-citation
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols
de Haar-Holleman, A. (2006) · Blood · doi:10.1182/blood-2006-04-015990 · Cited by 26
TRGV and TRDV repertoire distribution and clonality of T cells from umbilical cord blood
Li, Y., Chen, S., Yang, L., Li, B., Chan, J. Y.-H., & Cai, D. (2008) · Transplant Immunology · doi:10.1016/j.trim.2008.10.010 · Cited by 24
Purification and biotechnological applications of L-asparaginase from newly isolated Bacillus halotolerans OHEM18 as antitumor and antioxidant agent
El‐Fakharany, E. M., Orabi, H., Abdelkhalek, E. S., & Sidkey, N. M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1851300 · Cited by 24
Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
Ferguson, D. C. J., McCorkle, J. R., Barnett, K. R., Bonten, E. J., Bergeron, B. P., Bhattarai, K. R., Yang, W., Smith, C. J., Hansen, B. S., Bajpai, R., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022006965 · Cited by 24
Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro
Liu, W.-J., Wang, H., Peng, X.-W., Wang, W., Liu, N., Wang, Y., & Lu, Y. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s155930 · Cited by 24
Insights into the Microbial L-Asparaginases: from Production to Practical Applications
Sharma, D., Singh, K., Singh, K., & Mishra, A. (2018) · Current Protein and Peptide Science · doi:10.2174/1389203720666181114111035 · Cited by 24
Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia
Martino, L. D., Tosello, V., Peroni, E., & Piovan, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168738 · Cited by 25
Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukaemia
Leslie, M., Case, M. C., Hall, A. G., & Coulthard, S. A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05945.x · Cited by 24
Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP
Zhong, J., Chen, S., Xu, L., Lai, J., Liao, Z., Zhang, T., Yu, Z. H., Lu, Y., Yang, L., Wu, X., et al. (2016) · Hematology · doi:10.1080/10245332.2016.1155347 · Cited by 23
Gene expression of sHsps, Hsp40 and Hsp60 families in normal and abnormal embryonic development of mouse forelimbs
Zhu, Y., Zhu, J., Wan, X., Zhu, Y., & Zhang, T. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.01.016 · Cited by 22
The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia
Shen, Q., Liu, S., Hu, J., Chen, S., Yang, L., Li, B., Wu, X., Ma, Y., Yang, J., Ma, Y., et al. (2012) · Cancer Cell International · doi:10.1186/1475-2867-12-42 · Cited by 23
Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma
Li, Y., Zhang, X., Hu, T., Han, L., Li, R., Wen, J., & Zhang, M. (2014) · Oncology Reports · doi:10.3892/or.2014.3237 · Cited by 21
Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients
Abbatiello, S. E., Pan, Y., Zhou, M., Wayne, A. S., Veenstra, T. D., Hunger, S. P., Kilberg, M. S., Eyler, J. R., Richards, N. G. J., & Conrads, T. P. (2007) · Journal of Proteomics · doi:10.1016/j.jprot.2007.11.009 · Cited by 21
Expression of long-chain polyunsaturated fatty acids (LC-PUFA) biosynthesis genes and utilization of fatty acids during early development in rabbitfish Siganus canaliculatus
You, C., Miao, S., Lin, S., Wang, S., Waiho, K., & Li, Y. (2017) · Aquaculture · doi:10.1016/j.aquaculture.2017.07.028 · Cited by 20
Multiple Applications of Endophytic Colletotrichum Species Occurring in Medicinal Plants
Rai, M., Agarkar, G., & Rathod, D. (2014) · doi:10.1002/9781118460566.ch18 · Cited by 20
Asparaginases
Avramis, V. I. (2011) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31823313be · Cited by 19
Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapy
Yin, Q., Lin, C., Li, Q., Mi, R., Li, Y., Wei, X., & Song, Y. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0085-9 · Cited by 19
Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients
Chen, S., Zha, X., Yang, L., Li, B., Liye, Z., & Li, Y. (2011) · Hematology · doi:10.1179/102453311x12902908411832 · Cited by 18
Change in expression pattern of TCR–CD3 complex in patients with multiple myeloma
Li, Y., Chen, S., Yang, L., Chen, S., Lin, C., Wang, L., Lu, Y., Geng, S., Du, X., & Schmidt, C. A. (2011) · Hematology · doi:10.1179/102453311x12953015767491 · Cited by 18
The role of asparagine synthetase on nutrient metabolism in pancreatic disease
Tsai, C., Kilberg, M. S., & Husain, S. Z. (2020) · Pancreatology · doi:10.1016/j.pan.2020.08.002 · Cited by 18
Acute lymphoblastic leukemia
Pui, C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.014 · Cited by 18
Predictive markers for efficiency of the amino-acid deprivation therapies in cancer
Pokrovsky, V. S., Qoura, L. A., Morozova, E. A., & Bunik, V. I. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1035356 · Cited by 17
Enhancing Leukemia Treatment: The Role of Combined Therapies Based on Amino Acid Starvation
Chen, C., & Zhang, J. (2024) · Cancers · doi:10.3390/cancers16061171 · Cited by 18
Gene expression of Hsp70 , Hsp90 and Hsp110 families in normal palate and cleft palate during mouse embryogenesis
Zhu, Y., Ren, C., Wan, X., Zhu, Y., Zhu, J., Zhou, H., & Zhang, T. (2012) · Toxicology and Industrial Health · doi:10.1177/0748233712446720 · Cited by 16
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
Østergaard, A., Fiocco, M. F., de Groot‐Kruseman, H., Moorman, A. V., Vora, A. J., Zimmermann, M., Schrappe, M., Biondi, A., Escherich, G., Starý, J., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02287-7 · Cited by 15
The evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation
Chen, S., Huang, X., Zheng, H., Geng, S., Wu, X., Yang, L., Weng, J., Du, X., & Li, Y. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-73 · Cited by 15

Authors: Stams, W. A. G.
Affiliations: Erasmus MC (NL)
Corresponding author: Stams, W. A. G.
Venue: Blood
Publisher: American Society of Hematology
Published: 2002-11-14
Volume: 101
Issue: 7
Pages: 2743-2747
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2002-08-2446
OpenAlex: W2149324701
Cited by: 149
References: 35
Citations by year: 2026: 1 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 6 · 2021: 6 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 6 · 2015: 4 · 2014: 7 · 2013: 6 · 2012: 11
FWCI: 6.97
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Blood (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
RePub (Erasmus University Rotterdam) (submittedVersion)
Funders: Fondation pour la Recherche Médicale
Topics: Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords: L-asparaginase, asparagine synthetase, TEL-AML1 fusion, childhood acute lymphoblastic leukemia, B-lineage ALL, drug sensitivity, gene expression, chemoresistance
MeSH terms: Asparaginase, Aspartate-Ammonia Ligase, Child, Child, Preschool, Chromosomes, Human, Pair 12, Chromosomes, Human, Pair 21, Humans, Infant, RNA, Messenger, Translocation, Genetic, Leukemia, Lymphocytic, Chronic, B-Cell, Up-Regulation, Case-Control Studies, Precursor Cell Lymphoblastic Leukemia-Lymphoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks